Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 06-2016 | 06-2015 | 06-2014 | |
| Sales | 115,447 | 0 | 60,002 | 85,541 | 59,896 |
| Gross Profit | 115,447 | N/A | 60,002 | 85,541 | 59,896 |
| Operating Expenses | 174,429 | 0 | 184,993 | 139,996 | 131,427 |
| Operating Income | -58,982 | N/A | -124,991 | -54,455 | -71,531 |
| Interest Expense | 16,722 | 0 | 20,268 | 5,437 | 0 |
| Other Income | -20,308 | 0 | 442 | -847 | 167 |
| Pre-tax Income | -96,012 | 0 | -144,817 | -60,739 | -71,364 |
| Net Income Continuous | -96,012 | N/A | -144,817 | -60,739 | -71,364 |
| Net Income | $-96,012 | $N/A | $-144,817 | $-60,739 | $-71,364 |
| EPS Basic Total Ops | -0.98 | N/A | -1.67 | -0.71 | -0.83 |
| EPS Basic Continuous Ops | -0.98 | N/A | -1.67 | -0.71 | -0.83 |
| EPS Diluted Total Ops | -0.98 | N/A | -1.67 | -0.71 | -0.83 |
| EPS Diluted Continuous Ops | -0.98 | N/A | -1.67 | -0.71 | -0.83 |
| EPS Diluted Before Non-Recurring Items | -0.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-53,019 | $N/A | $-119,664 | $-48,942 | $-66,933 |